Pierce David A 4
4 · BOSTON SCIENTIFIC CORP · Filed Feb 17, 2022
Insider Transaction Report
Form 4
Pierce David A
SVP and President, Endoscopy
Transactions
- Exercise/Conversion
Common Stock
2022-02-15+2,769→ 2,769 total - Tax Payment
Common Stock
2022-02-15$44.01/sh−813$35,780→ 1,956 total - Sale
Common Stock
2022-02-16$43.81/sh−1,956$85,692→ 0 total - Exercise/Conversion
Deferred Stock Units
2022-02-15−2,769→ 2,769 totalExp: 2023-02-15→ Common Stock (2,769 underlying)
Footnotes (3)
- [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-l trading plan.
- [F3]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.